Research Article | Open Access
Lameck Ssemogerere, Cornelius Sendagire, Ceaser Mbabazi, Yvonne Namungoma, Anna Noland Oketayot, Judith Namuyonga, Cephas Mijumbi, Ritah Nkwine, Moses Othin, Michael Oketcho, John Paul Magala, Peter Lwabi, Arthur Kwizera, Martin W. Dünser, Christine Florence Najjuka, "Hand Colonization with Gram-Negative Organisms of Healthcare Workers Accessing the Cardiac Intensive Care Unit: A Cross-Sectional Study at the Uganda Heart Institute", Critical Care Research and Practice, vol. 2019, Article ID 6081954, 8 pages, 2019. https://doi.org/10.1155/2019/6081954
Hand Colonization with Gram-Negative Organisms of Healthcare Workers Accessing the Cardiac Intensive Care Unit: A Cross-Sectional Study at the Uganda Heart Institute
Background. Hands of healthcare workers (HCWs) are vehicles for pathogens responsible for healthcare-associated infections (HAIs). Following the identification of Gram-negative organisms (GNOs) in all cases of HAIs in the cardiac intensive care unit (ICU), we sought to determine the burden of hand colonization with GNOs among healthcare workers who access the cardiac ICU. Methods. We retrospectively reviewed results from surveillance cultures of fingertip imprints of HCWs who access the cardiac ICU at the Uganda Heart Institute. We collected data on staff category, isolates, and susceptibility to antibiotics. We analyzed the data using Microsoft Excel, and the results are summarized in proportions and percentages and presented in charts and tables. Results. Fifty-six healthcare workers participated in the surveillance. 21 were ICU clinicians, 21 non-ICU clinicians, and 14 nonclinicians. GNOs were cultured in 19 (33.9%) HCWs, in which 8/19 (42.1%) were non-ICU clinicians, 6/19 (31.2%) ICU clinicians, and 5/19 (26.3%) nonclinicians. 32 isolates were identified, of which 47%, 28%, and 25% were cultured from non-ICU clinicians, nonclinicians, and ICU clinicians, respectively. Predominant isolates were Acinetobacter (34%), Citrobacter (21.9%), and Pseudomonas (21.9%). Antimicrobial resistance ranged from 4% to 90%. 9/28 (32.1%) isolates, predominantly Acinetobacter species (spp), were carbapenem resistant. 8/28 (28.6%) isolates, predominantly Citrobacter spp, were multidrug resistant. Resistance to ciprofloxacin and cefepime was low at 3.6% and 4.4%, respectively. Conclusion. Gram-negative organisms, predominantly Acinetobacter, Citrobacter, and Pseudomonas spp, were prevalent on the hands of HCWs who access the cardiac ICU irrespective of the staff category. Antimicrobial resistance was high, with multidrug resistance and carbapenem resistance common among Citrobacter spp and Acinetobacter spp, respectively. Resistance to cefepime and ciprofloxacin was low.
Healthcare-associated infections (HAIs) remain a major threat to healthcare worldwide. HAIs in the intensive care unit are associated with very poor ICU and hospital outcomes [1–4]. Furthermore, HAIs in the ICU have worse outcomes compared to non-ICU-acquired infections . Transmission of these infections to patients is mainly via the hands of healthcare workers (HCWs). The colonized HCWs and ICU/hospital environment serve as reservoirs and the main risk factor for HAIs. [6–10].
Pathogenic Gram-negative organisms (GNOs) are commonly identified in patients with HAIs. They colonize patients, HCWs, and hospital environments during routine patient care and are common residents in the ICUs and other hospital wards [4, 6, 8, 11, 12]. The most prevalent pathogenic GNOs in health care worldwide are Acinetobacter, Pseudomonas, and Citrobacter spp [13–17]. The similarity of pathogens causing HAIs to those colonizing HCWs’ hands and hospital environment has been demonstrated . In one study, 21% of the infections were caused by GNOs found on personnel hands, and the predominant hand colonizers were found to be Acinetobacter (45%) and Klebsiella (39%) [9, 18].
Frequently, pathogenic GNOs colonizing staff hands and the hospital environment are multidrug resistant. Their potential to produce extended spectrum beta-lactamase (ESBL) and carbapenemase enzymes contributes to antimicrobial resistance and multidrug resistance (MDR) [17, 19–21]. At Mulago Hospital in Uganda, a study revealed carbapenem-resistant GNOs were present . The multidrug resistance makes GNOs very difficult to treat, leading to higher costs of healthcare and poor ICU and hospital outcomes [4, 13, 23, 24]. Noteworthy, these organisms can persist in the colonized environment and cause infection outbreaks [16, 25, 26]. With knowledge of such characteristics, deliberate efforts are needed to prevent colonization of the hospital environment and HCWs. To prevent transmission of pathogenic GNOs and other bacteria from patients to the hospital environment and vice versa, strict infection prevention and control (IPC) practices including hand hygiene are mandated. Proper hand hygiene reduces hand colonization with infection and is a superior practice in the prevention of infection transmission but requires HCWs’ compliance with optimal practices [8, 27].
In Uganda, we lack evidence on colonization of HCWs’ hands with GNOs and on IPC practices in the ICUs and other wards, yet MDR GNOs have been identified consistently from patients with HAIs admitted to these units [17, 22, 28]. The purpose of the study therefore was to determine the prevalence and antimicrobial susceptibility patterns of GNOs colonizing the hands of HCWs who have access to the cardiac ICU at the Uganda Heart Institute (UHI).
2.1. Study Design
This was a retrospective cross-sectional study conducted at UHI following the approval from UHI. We reviewed data generated during the surveillance activity by UHI in conjunction with the Department of Medical Microbiology, Makerere University College of Health Sciences (MakCHS). The surveillance lasted a week. Fingertip imprints were collected from HCWs who have access to the ICU. Samples were taken for culture and antibiotic susceptibility testing. The surveillance was specific for GNOs which were the only organisms identified from septic patients in the ICU between 2016 and 2018.
2.2. Study Setting
Uganda Heart Institute is a national referral center for cardiovascular services and the only facility in the country with the capacity to conduct cardiac surgery, both open and closed. UHI has one closed-type cardiac ICU with four fully functional beds. The unit admits up to 100 postoperative and approximately 200 nonsurgical cardiac patients per year. The ICU is run full time by a dedicated team of cardiac critical care specialists and operates with a 1 : 1 patient to nurse ratio at all times.
Non-ICU staff (both clinical and nonclinical) frequently have access to the ICU to provide specific services. They include cardiologists, surgeons, radiographers, theatre nurses, physiotherapists, biomedical technicians, catheterization laboratory nurses, resident doctors, and support staff. To reduce on the risk of postoperative infection, all patients undergoing surgery at UHI receive the World Health Organization (WHO) recommended prophylactic antibiotics before skin incision. Postoperatively, antibiotics are continued until all invasive catheters are removed. On average, patients receive prophylactic antibiotics for two to three days postoperatively. Cefuroxime is used at UHI for prophylaxis. Occasionally, other antibiotics like amikacin or gentamicin are added when sensitive GNOs are suspected.
2.3. Sample Collection and Processing
Sample collection and processing was led by the Department of Medical Microbiology at MakCHS. The department participated in proficiency testing by the American College of Pathologists (CAP NO. 732255-93-01).
Fingertip impressions were rolled on MacConkey media with and without cefotaxime 2 μg/ml and streaked for pure colonies. Samples were delivered to the lab within two hours of collection. The plates were incubated for 18–24 h at 35–37°C. Resulting colonies were subjected to further conventional biochemical tests for definitive identification. Antibiotic susceptibility testing was performed using the Kirby–Bauer disc diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) standards 2016 . Carbapenemase production testing was carried out using the modified carbapenem inactivation method . PCR detection for beta-lactamase genes (bla genes) was not performed. Results were available electronically and on hard paper.
2.4. Data Collection and Analysis
We reviewed all records of the results from surveillance cultures of fingertip imprints done on HCWs who participated in the surveillance. We did not exclude any record of the results. We collected data on HCWs’ designations, isolates, organism species, antibiotics, and susceptibility to antibiotics. We categorized HCWs as ICU clinicians (ICU-C), non-ICU clinicians (nICU-C), and nonclinicians (NC). In this study, clinicians refer to physicians and nurses while nonclinicians refer to all other staff. We grouped isolates under GNO species identified. For susceptibility to antibiotics, we assumed all intermediate and resistant isolates were nonsusceptible; herein, referred to as “resistant.” Resistance to three or more classes of antibiotics was defined as MDR. We analyzed data using Microsoft Excel, and the results are summarized in proportions and percentages and presented in tables and charts.
3.1. Staff Distribution
Fifty-six healthcare workers participated in the surveillance. 42/56 (75%) were clinicians and 14/56 (25%) were nonclinicians (NC). 50% (21/42) of the clinicians were ICU clinicians (ICU-C). Doctors were more than 50% in both ICU-C and nICU-C categories (Figure 1).
3.2. Culture Outcomes
Nineteen (33.9%) HCWs had positive cultures for GNOs. 5/19 (26.3%) were NC, 6/19 (31.6%) were ICU-C, and 8/19 (42.1%) were nICU-C. Non-ICU clinicians had the highest proportion of staff with positive cultures (Figure 2).
A total of 32 isolates and six GNO species were identified from 19 healthcare workers. 15/32 (46.9%) of the isolates were identified form non-ICU clinicians (Table 1).
3.3. Carbapenemase and ESBL Production
Twenty-eight (28) isolates were checked for susceptibility to antibiotics, and for carbapenemase, and ESBL production. 9 (32.1%) isolates, predominantly Acinetobacter spp, were carbapenemase producers (Figure 3). Of the nine, 5 were from ICU clinicians, 3 from non-ICU clinicians, and 1 from nonclinician. Three isolates (Acinetobacter, Klebsiella, and Enterobacter spp) were ESBL producers.
3.4. Antimicrobial Susceptibility
Resistance to antibiotics ranged from 4% to 90%. The lowest resistance was to ciprofloxacin and cefepime, at 3.6% and 4.4%, respectively (Table 2).
We found multidrug resistance in 8/28 (28.6%) isolates. Citrobacter spp were the most prevalent MDR isolates (4/8) (Table 3). Of the eight MDR isolates, four (50%) and three (37.5%) were identified from ICU clinicians and non-ICU clinicians, respectively.
Acinetobacter spp and Citrobacter spp were the predominant carbapenem and MDR isolates, respectively. The majority of Pseudomonas isolates were pan-sensitive. Noteworthy, only one Acinetobacter isolate was resistant to cotrimoxazole. In general, resistance to cefepime, ciprofloxacin, gentamicin, and cotrimoxazole was low (Table 4).
ACIN = Acinetobacter; CIT = Citrobacter; PSE = Pseudomonas; KLE = Klebsiella; SER = Serratia; ENT = Enterobacter; x = not tested.
Gram-negative organisms were prevalent on hands of HCWs who have access to the ICU at UHI. Acinetobacter, Citrobacter, and Pseudomonas species were the most common GNOs identified. Multidrug and carbapenem resistance were common, predominantly MDR-Citrobacter spp and carbapenem-resistant Acinetobacter spp. Other MDR isolates identified were Klebsiella, Enterobacter, and Serratia spp. The pathogens and their characteristics in this study are similar to those previously identified in studies conducted on patients at Mulago National Referral Hospital, Uganda [17, 22, 28].
This study offers the first research evidence on colonization of HCWs’ hands with GNOs in Uganda. With all the available evidence on the role of HCWs’ hands in the transmission of HAIs [31–33], we hypothesized that septic patients in the cardiac ICU could have been infected via colonized hands of HCWs. It is not uncommon for HCWs’ hands to get colonized during routine patient care and handling of contaminated surfaces in the ICU and other hospital environments [7, 9, 26, 32–34].
In this study, a third of HCWs who participated in the surveillance had GNOs cultured from their hands. Even though most isolates where identified from non-ICU clinicians, the majority of MDR and carbapenem-resistant isolates were identified from ICU clinicians. Nonclinicians who included cleaners, biomedical engineers, physiotherapists, and others were the fewest participants and majority of them were colonized. These colonization patterns have been reported in a few other studies [11, 32, 33]. Nonclinicians with the exception of physiotherapists rarely have direct contact with patients but routinely make contact with surfaces in the ICU and hospital environment. This puts them at equal risk of contamination and colonization thereafter becoming reservoirs and vehicles for pathogens [9, 26, 32].
Variations in standards of IPC practices and their implementation in the different units at the institute may partly explain why more non-ICU clinicians compared to ICU clinicians could be colonized with GNOs. The strict IPC practices in the ICU play a major role in the control of hand colonization and transmission of infection. However, to further reduce the risk of colonization of HCWs’ hands, standardized IPC guidelines must be implemented and adhered to in all sections of the hospital. Non-ICU clinicians and nonclinicians move frequently between the ICU and other areas in the hospital. These inevitable movements between places in a setting without adequate and accessible proper hand hygiene facilities promote poor hand hygiene and hand colonization with pathogenic microbes. [8, 18, 35–37].
The movement of HCWs between wards and hospitals can be associated with the colonization of the different wards and hospitals by the same pathogens . This may explain why HCWs from the different staff categories were colonized by similar GNOs. Nonclinicians just like the clinicians are continuously exposed to colonized hospital environments, hence the resemblance in colonization patterns [6, 10, 26, 37].
In general, ICU clinicians follow strict IPC guidelines including use of strong disinfectants, multiple hand antiseptics, and high-end antibiotics. Consequently, ICU clinicians are usually colonized by MDR pathogens. These organisms persist in the ICU environment and are difficult to eliminate, making ICUs permanent reservoirs [12, 18]. In this study, most of the MDR and carbapenem-resistant organisms were identified from the hands of ICU clinicians. These MDR organisms were similar to those found in previous studies on septic patients at Mulago Hospital in Uganda. This observation reflects the possibility of an already colonized hospital environment specifically ICU [17, 22, 28]. This implies that the hospital environment and clinicians are potential reservoirs for MDR GNOs. The potential for contamination of HCWs with organisms from a colonized work environment has been confirmed in some studies [9, 26, 33, 34].
Acinetobacter was the most prevalent GNO isolate cultured from the hands of HCWs (34.4%). This has been a consistent finding in many studies on GNO in the ICU and in patients with HAIs [4, 17, 18, 33, 38, 39]. Acinetobacter species continue to emerge as the most frequent high-prevalent GNO identified in HAIs in ICUs, on wards, and on HCWs and this has been demonstrated repeatedly [17, 22, 33, 40]. Pseudomonas and Citrobacter had equal prevalence (21.9%) and were the second commonest GNO isolate in this study. Unlike Pseudomonas, Citrobacter is relatively new as a cause of HAIs. It is currently one of the commonly isolated GNO in HAIs and a major threat to health care due to its ability to become MDR. [15, 33, 41–43].
Acinetobacter was the most prevalent carbapenem-resistant isolate (4/9) followed by Pseudomonas (2/9) and Citrobacter (2/9). These characteristics have been demonstrated before in other studies [20, 21, 44]. A majority of Acinetobacter isolates were resistant to piperacillin (54.4%) and to meropenem (36.4%), while Citrobacter isolates had a 28.6% resistance to meropenem. The single Klebsiella isolate and one Acinetobacter isolate exhibited extensive drug resistance. These resistance patterns are similar to those in a study done at Mulago Hospital, Uganda, on antimicrobial resistance in hospitalized surgical patients and another on nosocomial bacterial infections and their susceptibility patterns among ICU patients in Uganda [17, 28]. These studies demonstrated MDR characteristics amongst GNOs similar to those shown in this study. The findings of this study identify the emerging threat of MDR GNOs and carbapenem-resistant organisms in the ICU at UHI with a predominance of Acinetobacter which is known to persist in environments. This threat is a worldwide concern as described in multiple studies [45–48].
To prevent colonization of HCWs with pathogenic GNOs and other bacteria as well as transmission to patients and hospital environment, strict IPC must be implemented. These include proper hand hygiene as defined by the World Health Organization, surveillance for HAIs, antibiotic stewardship, and training of HCWs on infection and IPCs. Proper hand hygiene specifically hand washing reduces hand colonization with infections and is a superior practice in the prevention of infection transmission but requires HCWs’ compliance with optimal practices [8, 27].
At UHI, IPC was only emphasized and partially implemented in the ICU and operating theatre. There were no standardized guidelines on IPC for the hospital. Additionally, the facilities for hand hygiene such as hand washing basins and antimicrobial dispensers were few. This could have contributed to the emergency of sepsis caused by multidrug and carbapenem-resistant GNO observed in the cardiac ICU. There was no evidence of adherence to appropriate hand hygiene practices across the institute. Without proper hospital IPC guidelines, the risk of HAIs and colonization of both HCWs and hospital environment is magnified. The objective of the surveillance therefore was to identify the presence of carbapenem-resistant Gram-negative bacteria in the animate and inanimate environment as a likely source of what was observed in patients. The findings as discussed in this study were the basis for the establishment and funding of the IPC committee at UHI. The committee audits IPC practices, ensures training of staff on IPC and availability of appropriate hand hygiene facilities including antimicrobial dispensers, and monitors the implementation of standardized IPC guidelines. These interventions are expected to yield favorable outcomes in regard to IPC at UHI.
A few of HCWs who access ICU were not present at the time of collecting fingerprint samples. This obviously affects the proportions and percentages reported leading to either exaggeration or underreporting of results. The retrospective study design may have introduced selection and information bias. The findings of this study may not be adequate to influence practice in other settings.
GNOs were prevalent on the hands of HCWs who accessed the cardiac ICU in Uganda. Acinetobacter, Citrobacter, and Pseudomonas species were the most common GNOs identified. Both MDR and carbapenemase resistance were common. Half of the MDR GNOs were Citrobacter, while half of the carbapenem-resistant GNOs were Acinetobacter. Resistance to cefepime and ciprofloxacin was low.
The data used to support the findings of this study are included within the supplementary information file.
The study was approved by the Uganda Heart Institute Administration and Research Committee.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
LS conceived and designed the study. LS, CM, YN, ANO, RN, CFN, and CM participated in the review of records and data collection. LS, CS, OM, and AK analyzed the data. LS, CS, AK, JN, CFN, MO, JPM, PL, and MWD prepared the manuscript. All authors approved the final manuscript.
The authors would like to thank the Uganda Heart Institute Administration and Research Committee for approving and supporting the study, all staff who participated in the surveillance, the Department of Medical Microbiology, MakCHS, for conducting the surveillance, and the Division of Cardiac Critical Care at UHI for the vigilance in the identification and management of infections. Special thanks are due to Miss. Diana Ssemakula and Dr. Craig Sable for editing English grammar. The authors thank the Cardiac Critical Care Research Group-Uganda (CCCRG-Ug) for the leadership of the study.
The study describes colonization of healthcare workers’ hands with GNOs and the antimicrobial resistance patterns of the identified isolates. We analyzed data collected during surveillance for MDR GNO conducted at the Uganda Heart Institute (UHI). The surveillance was triggered by the emergency of MDR GNO in the cardiac intensive care unit (ICU). Therefore, we focused on healthcare workers who access the cardiac ICU. The prevalence of hand colonization with MDR GNO was high among healthcare workers of all categories who access the cardiac ICU. MDR and carbapenem resistance were common. Acinetobacter, Pseudomonas, and Citrobacter spp were the most prevalent. Resistance to cefepime and ciprofloxacin was low. We emphasize implementation of strict hospital-wide infection prevention and control (IPC) guidelines, hand hygiene inclusive as an immediate and efficient solution as recommended by the WHO. (Supplementary Materials)
- J. L. Vincent, D. J. Bihari, P. M. Suter et al., “The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC International Advisory Committee,” JAMA: The Journal of the American Medical Association, vol. 274, no. 8, pp. 639–644, 1995.
- C. Alberti, C. Brun-Buisson, H. Burchardi et al., “Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study,” Intensive Care Medicine, vol. 28, no. 2, pp. 108–121, 2002.
- J. Vallés, A. Pobo, O. García-Esquirol, D. Mariscal, J. Real, and R. Fernández, “Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset,” Intensive Care Medicine, vol. 33, no. 8, pp. 1363–1368, 2007.
- J.-L. Vincent, J. Rello, J. Marshall et al., “International study of the prevalence and outcomes of infection in intensive care units,” JAMA, vol. 302, no. 21, pp. 2323–2329, 2009.
- J.-L. Vincent, Y. Sakr, C. L. Sprung et al., “Sepsis in European intensive care units: results of the SOAP study,” Critical Care Medicine, vol. 34, no. 2, pp. 344–353, 2006.
- M. A. Knittle, D. V. Eitzman, and H. Baer, “Role of hand contamination of personnel in the epidemiology of gram-negative nosocomial infections,” The Journal of Pediatrics, vol. 86, no. 3, pp. 433–437, 1975.
- T. V. Riley, S. A. R. Webb, H. Cadwallader, B. D. Briggs, L. Christiansen, and R. A. Bowman, “Outbreak of gentamicin-resistant Acinetobacter baumanii in an intensive care unit: clinical, epidemiological and microbiological features,” Pathology, vol. 28, no. 4, pp. 359–363, 1996.
- B. Allegranzi and D. Pittet, “Role of hand hygiene in healthcare-associated infection prevention,” Journal of Hospital Infection, vol. 73, no. 4, pp. 305–315, 2009.
- E. Tajeddin, M. Rashidan, M. Razaghi et al., “The role of the intensive care unit environment and health-care workers in the transmission of bacteria associated with hospital acquired infections,” Journal of Infection and Public Health, vol. 9, no. 1, pp. 13–23, 2016.
- N. Ulrich, P. Gastmeier, and R.-P. Vonberg, “Effectiveness of healthcare worker screening in hospital outbreaks with gram-negative pathogens: a systematic review,” Antimicrobial Resistance & Infection Control, vol. 7, no. 1, p. 36, 2018.
- M. Pollack, R. E. Nieman, J. A. Reinhardt, P. Charache, M. P. Jett, and P. H. Hardy, “Factors influencing colonisation and antibiotic-resistance patterns of gram-negative bacteria in hospital patients,” The Lancet, vol. 300, no. 7779, pp. 668–671, 1972.
- S. W. Lemmen, H. Häfner, D. Zolldann, S. Stanzel, and R. Lütticken, “Distribution of multi-resistant Gram-negative versus Gram-positive bacteria in the hospital inanimate environment,” Journal of Hospital Infection, vol. 56, no. 3, pp. 191–197, 2004.
- A. K. Zaidi, W. C. Huskins, D. Thaver, Z. A. Bhutta, Z. Abbas, and D. A. Goldmann, “Hospital-acquired neonatal infections in developing countries,” The Lancet, vol. 365, no. 9465, pp. 1175–1188, 2005.
- J. Anguzu and D. Olila, “Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda,” African Health Sciences, vol. 7, no. 3, pp. 148–154, 2007.
- P. Gaibani, S. Ambretti, P. Farruggia et al., “Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012,” International Journal of Infectious Diseases, vol. 17, no. 9, pp. e714–e717, 2013.
- M. Dettori, A. Piana, M. G. Deriu et al., “Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit,” New Microbiologica, vol. 37, no. 2, pp. 185–191, 2014.
- P. Agaba, J. Tumukunde, J. V. B. Tindimwebwa, and A. Kwizera, “Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study,” BMC Research Notes, vol. 10, no. 1, p. 349, 2017.
- E. L. Larson, “Persistent carriage of gram-negative bacteria on hands,” American Journal of Infection Control, vol. 9, no. 4, pp. 112–119, 1981.
- E. Lautenbach, J. B. Patel, W. B. Bilker, P. H. Edelstein, and N. O. Fishman, “Extended-spectrum -Lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes,” Clinical Infectious Diseases, vol. 32, no. 8, pp. 1162–1171, 2001.
- L. Poirel and P. Nordmann, “Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology,” Clinical Microbiology and Infection, vol. 12, no. 9, pp. 826–836, 2006.
- A. P. Zavascki, C. G. Carvalhaes, R. C. Picão, and A. C. Gales, “Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy,” Expert Review of Anti-infective Therapy, vol. 8, no. 1, pp. 71–93, 2010.
- D. P. Kateete, R. Nakanjako, J. Namugenyi, J. Erume, M. L. Joloba, and C. F. Najjuka, “Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago hospital in Kampala, Uganda (2007–2009),” SpringerPlus, vol. 5, no. 1, p. 1308, 2016.
- E. Girou, F. Stephan, A. Novara, M. Safar, and J.-Y. Fagon, “Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 4, pp. 1151–1158, 1998.
- B. Digiovine, C. Chenoweth, C. Watts, and M. Higgins, “The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 3, pp. 976–981, 1999.
- S. I. Getchell-White, L. G. Donowitz, and D. H. M. Gröschel, “The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria evidence for long survival of Acinetobacter calcoaceticus,” Infection Control & Hospital Epidemiology, vol. 10, no. 9, pp. 402–407, 1989.
- D. J. Morgan, E. Rogawski, K. A. Thom et al., “Transfer of multidrug-resistant bacteria to healthcare workersʼ gloves and gowns after patient contact increases with environmental contamination,” Critical Care Medicine, vol. 40, no. 4, pp. 1045–1051, 2012.
- World Health Organization, WHO Guidelines on Hand Hygiene in Health Care, World Health Organization, Geneva, Switzerland, 2009.
- J. Seni, C. F. Najjuka, D. P. Kateete et al., “Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in Uganda,” BMC Research Notes, vol. 6, no. 1, p. 298, 2013.
- J. Patel and Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2016.
- V. M. Pierce, P. J. Simner, D. R. Lonsway et al., “Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae,” Journal of Clinical Microbiology, vol. 55, no. 8, pp. 2321–2333, 2017.
- M. Casewell and I. Phillips, “Hands as route of transmission for Klebsiella species,” BMJ, vol. 2, no. 6098, pp. 1315–1317, 1977.
- D. J. Morgan, S. Y. Liang, C. L. Smith et al., “Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers,” Infection Control & Hospital Epidemiology, vol. 31, no. 7, pp. 716–721, 2010.
- S. Singh and A. Singh, “Prevalence of bacteria contaminating the hands of healthcare workers during routine patient care: a hospital-based study,” Journal of The Academy of Clinical Microbiologists, vol. 18, no. 1, p. 60, 2016.
- R. Rosa, D. Depascale, T. Cleary, Y. Fajardo-Aquino, D. H. Kett, and L. S. Munoz-Price, “Differential environmental contamination with Acinetobacter baumannii based on the anatomic source of colonization,” American Journal of Infection Control, vol. 42, no. 7, pp. 755–757, 2014.
- D. Pittet, A. Simon, S. Hugonnet, C. L. Pessoa-Silva, V. Sauvan, and T. V. Perneger, “Hand hygiene among physicians: performance, beliefs, and perceptions,” Annals of Internal Medicine, vol. 141, no. 1, pp. 1–8, 2004.
- D. Pittet and L. Donaldson, “Clean care is safer care: the first global challenge of the WHO World Alliance for Patient Safety,” Infection Control & Hospital Epidemiology, vol. 26, no. 11, pp. 891–894, 2005.
- D. Pittet, B. Allegranzi, and J. Boyce, “The World Health Organization guidelines on hand hygiene in health care and their consensus recommendations,” Infection Control & Hospital Epidemiology, vol. 30, no. 7, pp. 611–622, 2009.
- G. M. Tran, T. P. Ho-Le, D. T. Ha et al., “Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam,” BMC Infectious Diseases, vol. 17, no. 1, p. 429, 2017.
- S. F. Hormozi, A. A. Saeedi, M. Aminianfar, M. S. Alishah, and M. Darvishi, “Studying the frequency of nosocomial infection and its relative factors in the intensive care unit of hospitals based upon NNI system,” Eurasian Journal Of Analytical Chemistry, vol. 13, no. 3, p. em16, 2018.
- D. H. Forster and F. D. Daschner, “Acinetobacter species as nosocomial pathogens,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 17, no. 2, pp. 73–77, 1998.
- X.-c. Yu, M.-y. Zhu, and D.-z. Zhang, “Character of hospital infection and multidrug resistance of Citrobacter,” Chinese Journal of Nosocomiology, vol. 19, no. 12, pp. 1603–1605, 2009, in Chinese.
- S. B. Khadka, B. Thapa, and K. Mahat, “Nosocomial Citrobacter infection in neonatal intensive care unit in a hospital of Nepal,” Journal of Nepal Paediatric Society, vol. 31, no. 2, pp. 105–109, 2011.
- J. Agarwal, S. Mohan, R. Srivastava, and M. Singh, “Observations on Citrobacter species from a tertiary care health center with special reference to multi-drug resistance and presence of CTX-M gene,” Indian Journal of Pathology and Microbiology, vol. 57, no. 3, p. 439, 2014.
- G. M. Eliopoulos, L. L. Maragakis, and T. M. Perl, “Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options,” Clinical Infectious Diseases, vol. 46, no. 8, pp. 1254–1263, 2008.
- B. Allegranzi, S. B. Nejad, C. Combescure et al., “Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis,” The Lancet, vol. 377, no. 9761, pp. 228–241, 2011.
- S. Blot, K. Vandewoude, K. Blot, and F. Colardyn, “Prevalence and risk factors for colonisation with gram-negative bacteria in an intensive care unit,” Acta Clinica Belgica, vol. 55, no. 5, pp. 249–256, 2000.
- R. M. Daud-Gallotti, S. F. Costa, T. Guimarães et al., “Nursing workload as a risk factor for healthcare associated infections in ICU: a prospective study,” PLoS One, vol. 7, no. 12, Article ID e52342, 2012.
- R. Reid, C. Sheehy, and L. Jabbour, “Risk factors and interventions against nosocomial infections across multiple African countries: a systematic review,” CPQ Medicine, vol. 2, 2 pages, 2018.
Copyright © 2019 Lameck Ssemogerere et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.